BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

366 related articles for article (PubMed ID: 35379307)

  • 1. A deprescribing medication program to evaluate falls in older adults: methods for a randomized pragmatic clinical trial.
    Niznik J; Ferreri SP; Armistead L; Urick B; Vest MH; Zhao L; Hughes T; McBride JM; Busby-Whitehead J
    Trials; 2022 Apr; 23(1):256. PubMed ID: 35379307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacist interventions to deprescribe opioids and benzodiazepines in older adults: A rapid review.
    Niznik JD; Collins BJ; Armistead LT; Larson CK; Kelley CJ; Hughes TD; Sanders KA; Carlson R; Ferreri SP
    Res Social Adm Pharm; 2022 Jun; 18(6):2913-2921. PubMed ID: 34281786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary-Care Prescribers' Perspectives on Deprescribing Opioids and Benzodiazepines in Older Adults.
    Niznik JD; Ferreri SP; Armistead LT; Kelley CJ; Schlusser C; Hughes T; Henage CB; Busby-Whitehead J; Roberts E
    Drugs Aging; 2022 Sep; 39(9):739-748. PubMed ID: 35896779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A health-system-embedded deprescribing intervention targeting patients and providers to prevent falls in older adults (STOP-FALLS trial): study protocol for a pragmatic cluster-randomized controlled trial.
    Balderson BH; Gray SL; Fujii MM; Nakata KG; Williamson BD; Cook AJ; Wellman R; Theis MK; Lewis CC; Key D; Phelan EA
    Trials; 2023 May; 24(1):322. PubMed ID: 37170329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patient Perceptions of Opioids and Benzodiazepines and Attitudes Toward Deprescribing.
    Kelley CJ; Niznik JD; Ferreri SP; Schlusser C; Armistead LT; Hughes TD; Henage CB; Busby-Whitehead J; Roberts E
    Drugs Aging; 2023 Dec; 40(12):1113-1122. PubMed ID: 37792262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The OPTIMIZE patient- and family-centered, primary care-based deprescribing intervention for older adults with dementia or mild cognitive impairment and multiple chronic conditions: study protocol for a pragmatic cluster randomized controlled trial.
    Bayliss EA; Shetterly SM; Drace ML; Norton J; Green AR; Reeve E; Weffald LA; Wright L; Maciejewski ML; Sheehan OC; Wolff JL; Gleason KS; Kraus C; Maiyani M; Du Vall M; Boyd CM
    Trials; 2020 Jun; 21(1):542. PubMed ID: 32552857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leveraging policy to reduce chronic opioid use by educating and empowering community dwelling adults: a study protocol for the TAPERING randomized controlled trial.
    Turner JP; Caetano P; Tannenbaum C
    Trials; 2019 Jul; 20(1):412. PubMed ID: 31288859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessing the Efficacy of the ARMOR Tool-Based Deprescribing Intervention for Fall Risk Reduction in Older Patients Taking Fall Risk-Increasing Drugs (DeFRID Trial): Protocol for a Randomized Controlled Trial.
    Priyadarshini R; Eerike M; Varatharajan S; Ramaswamy G; Raj GM; Cherian JJ; Rajendran P; Gunasekaran V; Rao SV; Konda VGR
    JMIR Res Protoc; 2024 Jun; 13():e55638. PubMed ID: 38861709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deprescribing Benzodiazepines in Older Patients: Impact of Interventions Targeting Physicians, Pharmacists, and Patients.
    Ng BJ; Le Couteur DG; Hilmer SN
    Drugs Aging; 2018 Jun; 35(6):493-521. PubMed ID: 29705831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spread and scale of an electronic deprescribing software to improve health outcomes of older adults living in nursing homes: study protocol for a stepped wedge cluster randomized trial.
    Nadeau ME; Henry JL; Lee TC; Bortolussi-Courval É; Goodine C; McDonald EG
    Trials; 2021 Nov; 22(1):763. PubMed ID: 34727956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deprescribing to reduce polypharmacy: study protocol for a randomised controlled trial assessing deprescribing of anticholinergic and sedative drugs in a cohort of frail older people living in the community.
    Bergler U; Ailabouni NJ; Pickering JW; Hilmer SN; Mangin D; Nishtala PS; Jamieson H;
    Trials; 2021 Nov; 22(1):766. PubMed ID: 34732234
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deprescribing of benzodiazepines and Z-drugs amongst the psychiatric patients of a tertiary care Hospital.
    Shilpa HSS; Kumar NN; Maheswari E; Virupaksha HS; Subeesh V; Saraswathy GR; Kunnavil R
    Asian J Psychiatr; 2019 Aug; 44():189-194. PubMed ID: 31408799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrating targeted consultant pharmacists into a new collaborative care model to reduce the risk of falls in older adults owing to the overuse of opioids and benzodiazepines.
    Armistead LT; Hughes TD; Larson CK; Busby-Whitehead J; Ferreri SP
    J Am Pharm Assoc (2003); 2021; 61(1):e16-e18. PubMed ID: 32933865
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness of a multi-faceted intervention to deprescribe proton pump inhibitors in primary care: protocol for a population-based, pragmatic, cluster-randomized controlled trial.
    Nguyen-Soenen J; Rat C; Gaultier A; Schirr-Bonnans S; Tessier P; Fournier JP
    BMC Health Serv Res; 2022 Feb; 22(1):219. PubMed ID: 35177042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of a Pharmacist-Led Educational Intervention on Inappropriate Medication Prescriptions in Older Adults: The D-PRESCRIBE Randomized Clinical Trial.
    Martin P; Tamblyn R; Benedetti A; Ahmed S; Tannenbaum C
    JAMA; 2018 Nov; 320(18):1889-1898. PubMed ID: 30422193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deprescribing for older people living in residential aged care facilities: Pharmacist recommendations, doctor acceptance and implementation.
    Quek HW; Etherton-Beer C; Page A; McLachlan AJ; Lo SY; Naganathan V; Kearney L; Hilmer SN; Comans T; Mangin D; Lindley RI; Potter K
    Arch Gerontol Geriatr; 2023 Apr; 107():104910. PubMed ID: 36565605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deprescribing Education vs Usual Care for Patients With Cognitive Impairment and Primary Care Clinicians: The OPTIMIZE Pragmatic Cluster Randomized Trial.
    Bayliss EA; Shetterly SM; Drace ML; Norton JD; Maiyani M; Gleason KS; Sawyer JK; Weffald LA; Green AR; Reeve E; Maciejewski ML; Sheehan OC; Wolff JL; Kraus C; Boyd CM
    JAMA Intern Med; 2022 May; 182(5):534-542. PubMed ID: 35343999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Economic Evaluation of Sedative Deprescribing in Older Adults by Community Pharmacists.
    Turner JP; Sanyal C; Martin P; Tannenbaum C
    J Gerontol A Biol Sci Med Sci; 2021 May; 76(6):1061-1067. PubMed ID: 32761069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Community-based pharmacists' role in deprescribing: A systematic review.
    Bužančić I; Kummer I; Držaić M; Ortner Hadžiabdić M
    Br J Clin Pharmacol; 2022 Feb; 88(2):452-463. PubMed ID: 34155673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Older Adult and Primary Care Practitioner Perspectives on Using, Prescribing, and Deprescribing Opioids for Chronic Pain.
    Anderson TS; Wang BX; Lindenberg JH; Herzig SJ; Berens DM; Schonberg MA
    JAMA Netw Open; 2024 Mar; 7(3):e241342. PubMed ID: 38446478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.